Overview

Kestra Medical Technologies develops digital healthcare devices that protect at-risk cardiac patients. Its flagship ASSURE Wearable Cardioverter Defibrillator system continuously monitors heart rhythm, autonomously detects dangerous rhythms, and delivers defibrillation therapy; it also includes a remote patient data platform for clinicians and a patient app to support recovery. The device combines sensing, detection, and therapy with remote management and payer partnerships to expand access in the United States. Its goal is to improve outcomes for at-risk cardiac patients by making lifesaving defibrillation more widely available.